Conference Coverage
Latest News
Nov 18, 2025 | Commentary
Exploring the Growth and Challenges of Genetic Counselling: Carrie Haverty, MS, CGC
Study Forecasts Uptick in ALS Prevalence in Coming Decades
Nov 18, 2025
Targeting Myasthenia Gravis at the Source: Promising Progress of CAR-T Agent KYV-101
Nov 18, 2025
Nerivio REN Wearable Delivers Consistent Drug-Free Relief Over 3 Years, Study Shows
Nov 17, 2025
Decoding the Circuitry That Stabilizes Memory Maps in the Hippocampus
Nov 17, 2025
Advertisement
Shorts
1:30
Collaboration Within the ALS Community
6 days ago
by
Jinsy A. Andrews, MD, MSc(+1 more)
1:30
Safety Considerations for Kygevvi in Tk2d
7 days ago
by
Fabian Somers, PhD(+1 more)
1:30
Data Backing First Treatment for Tk2d
8 days ago
by
Fabian Somers, PhD(+1 more)
1:30
Training the Next Neuromuscular Specialists
12 days ago
by
John Norbury, MD(+1 more)
1:15
Evolving Landscape of Myasthenia Gravis Treatment
16 days ago
by
Leila Darki, MD(+1 more)
1:05
Aerobic Exercise and Promoting Remyelination in MS
a month ago
by
Lindsey Wooliscroft, MD, MS(+1 more)
1:12
MDS 2025: Learning From Progress in Other Disease States
a month ago
by
Lorraine Kalia, MD, PhD(+1 more)
1:16
MDS 2025: Biologically Defining Parkinson Disease
a month ago
by
Tanya Simuni, MD, FAAN(+1 more)
1:32
MDS 2025: Environmental Exposures and PD
a month ago
by
Web Ross, MD(+1 more)
0:53
MDS 2025: Novel Therapeutics and Biomarkers for PD
a month ago
by
Veronica Santini, MD, MA(+1 more)
Coverage of MDS Congress 2025
Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in Honolulu.
Coverage of AANEM 2025
Get direct access to interviews with experts, straight from the conference floor in San Francisco, as well as the latest data and clinical news updates.
Mind Moments Podcast
Mind Moments® is a biweekly podcast from NeurologyLive that brings you exclusive interviews with expert neurologists and clinicians.
DAMM Good Sleep
Check out DAMM Good Sleep × NeurologyLive for neurology-focused sleep content to allow any neurology stakeholder to use sleep as the diagnostic, prognostic, and therapeutic neurology tool it should be.
NeuroVoices
NeuroVoices is NeurologyLive's series of in-depth, exclusive Q&A conversations with a variety of experts in the care and management of patients with neurologic diseases about topics in clinical care and therapeutic development.
Podcasts
Continuing Medical Education
Advertisement
All News
Advertisement
Clene Nanomedicine prepares to submit an NDA for CNM-Au8, a promising ALS treatment, aiming for accelerated FDA approval by 2026.
Here's some of what is coming soon to NeurologyLive® this week.
Spencer Hutto, MD, associate program director of the adult neurology residency at Emory University, outlined the key diagnostic nuances, treatment considerations, and emerging therapeutic strategies shaping modern neurosarcoidosis care.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on CAR-T therapy for autoimmune neurologic diseases!
Cladribine shows superior efficacy over S1P modulators in reducing disability progression in treatment-naive relapsing-remitting MS patients.
The assistant professor of neurology at Northwestern University explained key diagnostic, therapeutic, and management considerations for clinicians caring for patients with NMOSD across diverse and evolving clinical scenarios.
The agency has required a postmarketing observational study to monitor safety for at least 12 months following gene therapy treatment in patients with Duchenne muscular dystrophy.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 14, 2025.
Centessa Pharmaceuticals reveals promising early-stage results for its orexin receptor 2 agonists, ORX750 and ORX142, targeting neurologic sleep disorders.
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with James Berry, MD, MPH; and Jinsy Andrews, MD, MSc. [LISTEN TIME: 28 minutes]
Advertisement
Beatrice Yang, MD, lead specialist for patient insights at Lundbeck, discussed how incorporating patient and caregiver feedback helped shape the design of a phase 3 multiple system atrophy trial to make participation more practical and patient-centered.
Eva Mistry, MD, an associate professor of neurology at the University of Cincinnati, discusses the mechanism, rationale, and clinical data supporting SCP776, a first-in-class IGF-1-based cerebroprotective therapy for acute ischemic stroke.
The phase 3 FORTIFY trial of BBP-418 met its primary and key secondary interim analysis end points and demonstrated a safety profile consistent with prior studies in patients with LGMD2I/R9.
Liche Zhou, MD, of the department of neurology at Jiang University School of Medicine, provided commentary on new phase 1 data on an iPSC-targeted cell therapy presented at the 2025 MDS Congress.
New trial results reveal alixorexton's significant efficacy in treating narcolepsy type 2, marking a potential breakthrough in sleep medicine.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Exploring the Growth and Challenges of Genetic Counselling: Carrie Haverty, MS, CGC
2
Clene to Submit Application for CNM-Au8 as Potential ALS Treatment
3
Study Forecasts Uptick in ALS Prevalence in Coming Decades
4
Targeting Myasthenia Gravis at the Source: Promising Progress of CAR-T Agent KYV-101
5
